RxDoctor Payments Data

Andrew Klann

Family Medicine · Platteville, WINPI 1134380876

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.6% of the total across 482 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,695in general payments, 2019–2025

Across 482 payments — averaging $15.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$1K
  • Boehringer Ingelheim$623
  • Amgen$621
  • Lilly USA, LLC$617
  • AstraZeneca$455
  • plus $3K from 36 others

What the payments were for

  • Consulting fees$1752%
  • Food & beverage$7,50898%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,695 in reported general payments places this provider in the 95th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban81$92,067
JardianceEmpagliflozin57$88,126
XareltoRivaroxaban55$45,025
TrulicityDulaglutide24$40,269
TradjentaLinagliptin44$36,758
FarxigaDapagliflozin Propanediol25$36,008
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog24$30,971
OzempicSemaglutide27$30,487
MounjaroTirzepatide15$24,528
JanuviaSitagliptin Phosphate15$21,534
Breo ElliptaFluticasone/Vilanterol34$18,080
Spiriva RespimatTiotropium Bromide20$15,859
Tresiba Flextouch U-200Insulin Degludec11$12,045
MyrbetriqMirabegron17$9,422
Combivent RespimatIpratropium/Albuterol Sulfate12$6,032

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat, Combivent Respimat$623$146,776133 claims
PfizerEliquis$1,029$92,06781 claims
Lilly USA, LLCTrulicity, Mounjaro$617$64,79839 claims
Johnson & JohnsonXarelto$183$45,02555 claims
AstraZenecaFarxiga, Symbicort$455$38,66636 claims
Novo NordiskOzempic$242$30,48727 claims
MerckJanuvia$113$21,53415 claims
GSKBreo Ellipta$29$18,08034 claims
Astellas Pharma US IncMyrbetriq$312$9,42217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,482 family medicine providers in Wisconsin.

Other family medicine in Platteville

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →